Research ExplorerPublicationsGuidelines of the International Headache Society for Control...

Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache

Standard

Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache. / Schoenen, Jean; Snoer, Agneta Henriette; Brandt, Roemer B; Fronczek, Rolf; Wei, Diana Y; Chung, Chin-Sang; Diener, Hans-Christoph; Dodick, David W; Fontaine, Denys; Goadsby, Peter J; Matharu, Manjit Singh; May, Arne; McGinley, James S; Tepper, Stewart J; Jensen, Rigmor Højland; Ferrari, Michel D; IHS Standing Committee for Clinical Trials.

In: CEPHALALGIA, Vol. 42, No. 14, 12.2022, p. 1450-1466.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Schoenen, J, Snoer, AH, Brandt, RB, Fronczek, R, Wei, DY, Chung, C-S, Diener, H-C, Dodick, DW, Fontaine, D, Goadsby, PJ, Matharu, MS, May, A, McGinley, JS, Tepper, SJ, Jensen, RH, Ferrari, MD & IHS Standing Committee for Clinical Trials 2022, 'Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache', CEPHALALGIA, vol. 42, no. 14, pp. 1450-1466. https://doi.org/10.1177/03331024221120266

APA

Schoenen, J., Snoer, A. H., Brandt, R. B., Fronczek, R., Wei, D. Y., Chung, C-S., Diener, H-C., Dodick, D. W., Fontaine, D., Goadsby, P. J., Matharu, M. S., May, A., McGinley, J. S., Tepper, S. J., Jensen, R. H., Ferrari, M. D., & IHS Standing Committee for Clinical Trials (2022). Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache. CEPHALALGIA, 42(14), 1450-1466. https://doi.org/10.1177/03331024221120266

Vancouver

Schoenen J, Snoer AH, Brandt RB, Fronczek R, Wei DY, Chung C-S et al. Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache. CEPHALALGIA. 2022 Dec;42(14):1450-1466. https://doi.org/10.1177/03331024221120266

Bibtex

@article{7201abb7bafc4865843148f9a45e103d,
title = "Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache",
abstract = "In 1995, a committee of the International Headache Society developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Cluster Headache. These have not been revised. With the emergence of new medications, neuromodulation devices and trial designs, an updated version of the International Headache Society Guidelines for Controlled Clinical Trials in Cluster Headache is warranted. Given the scarcity of evidence-based data for cluster headache therapies, the update is largely consensus-based, but takes into account lessons learned from recent trials and demands by patients. It is intended to apply to both drug and neuromodulation treatments, with specific proposals for the latter when needed. The primary objective is to propose a template for designing high quality, state-of-the-art, controlled clinical trials of acute and preventive treatments in episodic and chronic cluster headache. The recommendations should not be regarded as dogma and alternative solutions to particular methodological problems should be explored in the future and scientifically validated.",
keywords = "Humans, Cluster Headache/drug therapy, Headache/therapy, Controlled Clinical Trials as Topic",
author = "Jean Schoenen and Snoer, {Agneta Henriette} and Brandt, {Roemer B} and Rolf Fronczek and Wei, {Diana Y} and Chin-Sang Chung and Hans-Christoph Diener and Dodick, {David W} and Denys Fontaine and Goadsby, {Peter J} and Matharu, {Manjit Singh} and Arne May and McGinley, {James S} and Tepper, {Stewart J} and Jensen, {Rigmor H{\o}jland} and Ferrari, {Michel D} and {IHS Standing Committee for Clinical Trials}",
year = "2022",
month = dec,
doi = "10.1177/03331024221120266",
language = "English",
volume = "42",
pages = "1450--1466",
journal = "CEPHALALGIA",
issn = "0333-1024",
publisher = "SAGE Publications",
number = "14",

}

RIS

TY - JOUR

T1 - Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache

AU - Schoenen, Jean

AU - Snoer, Agneta Henriette

AU - Brandt, Roemer B

AU - Fronczek, Rolf

AU - Wei, Diana Y

AU - Chung, Chin-Sang

AU - Diener, Hans-Christoph

AU - Dodick, David W

AU - Fontaine, Denys

AU - Goadsby, Peter J

AU - Matharu, Manjit Singh

AU - May, Arne

AU - McGinley, James S

AU - Tepper, Stewart J

AU - Jensen, Rigmor Højland

AU - Ferrari, Michel D

AU - IHS Standing Committee for Clinical Trials

PY - 2022/12

Y1 - 2022/12

N2 - In 1995, a committee of the International Headache Society developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Cluster Headache. These have not been revised. With the emergence of new medications, neuromodulation devices and trial designs, an updated version of the International Headache Society Guidelines for Controlled Clinical Trials in Cluster Headache is warranted. Given the scarcity of evidence-based data for cluster headache therapies, the update is largely consensus-based, but takes into account lessons learned from recent trials and demands by patients. It is intended to apply to both drug and neuromodulation treatments, with specific proposals for the latter when needed. The primary objective is to propose a template for designing high quality, state-of-the-art, controlled clinical trials of acute and preventive treatments in episodic and chronic cluster headache. The recommendations should not be regarded as dogma and alternative solutions to particular methodological problems should be explored in the future and scientifically validated.

AB - In 1995, a committee of the International Headache Society developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Cluster Headache. These have not been revised. With the emergence of new medications, neuromodulation devices and trial designs, an updated version of the International Headache Society Guidelines for Controlled Clinical Trials in Cluster Headache is warranted. Given the scarcity of evidence-based data for cluster headache therapies, the update is largely consensus-based, but takes into account lessons learned from recent trials and demands by patients. It is intended to apply to both drug and neuromodulation treatments, with specific proposals for the latter when needed. The primary objective is to propose a template for designing high quality, state-of-the-art, controlled clinical trials of acute and preventive treatments in episodic and chronic cluster headache. The recommendations should not be regarded as dogma and alternative solutions to particular methodological problems should be explored in the future and scientifically validated.

KW - Humans

KW - Cluster Headache/drug therapy

KW - Headache/therapy

KW - Controlled Clinical Trials as Topic

U2 - 10.1177/03331024221120266

DO - 10.1177/03331024221120266

M3 - Other (editorial matter etc.)

C2 - 36268950

VL - 42

SP - 1450

EP - 1466

JO - CEPHALALGIA

JF - CEPHALALGIA

SN - 0333-1024

IS - 14

ER -